n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and 15-keto-13,14-dihydroprostaglandin f2alpha

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with 15-keto-13,14-dihydroprostaglandin f2alpha in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alonso, MJ; Alvarez, Y; Balfagón, G; Briones, AM; Salaices, M1

Other Studies

1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and 15-keto-13,14-dihydroprostaglandin f2alpha

ArticleYear
Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses.
    Journal of hypertension, 2005, Volume: 23, Issue:4

    Topics: Animals; Aorta; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Endothelium, Vascular; Hypertension; Male; Nitrobenzenes; Phenylephrine; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents

2005